India’s growth story has unfolded excellent business opportunities for the Indian Pharmaceutical Industry. The industry has demonstrated impressive expansion across all its segments over the last few years while rapidly integrating with the global industry. India is now high on the radar of multinational pharmaceutical companies who are increasingly looking at outsourcing business functions such as process synthesis, analytical development, and manufacturing, to focus on drug discovery and brand management in an initiative to develop cost effective business models. India is also concurrently developing its NCE portfolios and is gearing up to launch its own patented molecules globally over the medium term. To cope with the high cost and risks attached with clinical development of a new drug, Indian companies have collaborated with the Big Pharma through licensing and joint development agreements.